7Baggers
Quarterly
Annual
    Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 
      
                  
      cash flows from operating activities
                  
      net income
    -5,266,000 -6,061,000 -33,947,000 -25,823,000 -40,668,000 -46,829,000 -36,960,000 -31,815,000 -27,902,000 -26,889,000 -21,188,000 -16,805,000 -53,929,000 -67,887,000 
      adjustments to reconcile net income to net cash from operating activities:
                  
      depreciation
    241,000 250,000 476,000 476,000 468,000 456,000 429,000 344,000 105,000 1,000     
      stock-based compensation
    2,330,000 2,429,000 4,479,000 5,050,000 6,061,000 5,194,000 3,756,000 3,946,000 3,246,000 2,642,000 1,331,000 844,000 556,000 272,000 
      amortization of operating lease right-of-use assets
    237,000 240,000 378,000 366,000 327,000 251,000 295,000 309,000 313,000 360,000     
      impairment of long-lived assets
      8,364,000           
      amortization of debt discount
      162,000 159,000 157,000 155,000 129,000 126,000 110,000 101,000   
      issuance (payment) of pik interest debt
                 
      acquired in-process research and development
      15,325,000       2,500,000 
      net accretion/amortization of premiums and discounts on marketable securities
    -955,000 -804,000 -460,000 -1,135,000 -1,498,000 -1,299,000         
      loss on disposal of property and equipment
    92,000 148,000         42,000 
      changes in operating assets and liabilities:
                  
      prepaid expenses and other current assets
    3,348,000 1,338,000 945,000 -374,000 869,000 -1,160,000 1,590,000 204,000 328,000 1,895,000 -3,120,000 -3,201,000 -4,411,000 -339,000 
      accounts payable, accrued expenses and other long-term liabilities
    -319,000 -9,784,000 2,037,000 -6,679,000 -3,466,000 -5,180,000 9,945,000 -672,000 747,000 4,384,000 3,532,000 -1,263,000   
      accrued interest
      -131,000 -4,000 1,000 6,000 26,000 23,000 24,000 29,000 2,000 757,000 2,064,000 
      operating lease liabilities
    -497,000 -474,000        1,409,000     
      net cash from operating activities
    -789,000 -12,718,000 -18,188,000 -27,822,000 -29,779,000 -33,002,000 -21,606,000 -26,806,000 -22,417,000 -15,954,000 -18,517,000 -19,547,000 -13,210,000 -10,715,000 
      capex
    -110,000 -212,000 -47,000 -153,000 -738,000 -2,186,000 -4,839,000 -2,985,000 
      free cash flows
    -789,000 -12,718,000 -18,298,000 -28,034,000 -29,826,000 -33,155,000 -22,344,000 -28,992,000 -27,256,000 -18,939,000 -18,517,000 -19,547,000 -13,210,000 -10,715,000 
      cash flows from investing activities
                  
      cash paid for purchased in-process research and development
      -1,500,000 -13,825,000     -2,500,000 
      purchases of property and equipment
      -110,000 -212,000 -47,000 -153,000 -738,000 -2,186,000 -4,839,000 -2,985,000     
      purchases of marketable securities
    -6,019,000 -111,264,000 1,000 -15,694,000 -46,921,000 -92,684,000 -14,693,000 -43,988,000       
      proceeds from sales or maturities of marketable securities
    18,000,000 17,000,000 69,000,000 68,045,000 43,500,000 49,000,000 44,900,000        
      net cash from investing activities
    11,981,000 -94,264,000 68,891,000 50,639,000 -3,468,000 -57,662,000 29,469,000 -31,174,000 -89,948,000 -2,985,000 -3,829,000 -185,000 -2,500,000 
      cash flows from financing activities
                  
      proceeds from issuance of common stock under share-based compensation arrangements
      615,000 175,000         
      proceeds from issuance of at-the-market offering
      14,887,000         
      net cash from financing activities
      -27,497,000 615,000 15,062,000 313,000 108,107,000 10,198,000 80,000 9,687,000 -2,820,000 218,201,000 -99,000 
      net decrease in cash, cash equivalents and restricted cash
    11,192,000 -106,982,000 50,703,000 -4,680,000 -32,632,000 -75,602,000    -18,859,000     
      cash, cash equivalents and restricted cash—beginning of period
    156,098,000 218,309,000 281,032,000   
      cash, cash equivalents and restricted cash—end of period
    11,192,000 49,116,000 50,703,000 -4,680,000 -32,632,000 142,707,000 8,176,000 50,127,000 -102,167,000 262,173,000 -12,659,000 -22,552,000   
      supplemental disclosure of cash flow information
                  
      cash paid for interest
      156,000 387,000 382,000 271,000 660,000 269,000 192,000 89,000 74,000   
      supplemental disclosure of noncash investing and financing activities
                  
      unpaid in-process research and development
        1,500,000         
      unpaid property and equipment purchases
        311,000 13,000 -35,000 -1,241,000 -2,041,000 3,453,000 1,158,000    
      accreted final interest payment fees
        128,000 124,000 124,000 122,000 108,000 109,000 94,000 88,000   
      loss on extinguishment of debt
                 
      operating lease right-of-use assets and liabilities
      -460,000 -439,000 -443,000 -94,000 48,000 1,800,000    748,000 750,000 4,000 
      repayment of long-term debt, including fees
                 
      proceeds from issuance of common stock in underwritten public offering, net of issuance costs
          -310,000        
      proceeds from issuance of long-term debt, net of issuance costs
            10,000,000   
      unpaid underwritten public offering costs
                  
      issuance of pik interest debt
        178,000 174,000 173,000 170,000 111,000 94,000 39,000 27,000   
      change in fair value of convertible promissory notes
              34,396,000 17,073,000 
      change in fair value of warrant liabilities - related party
              6,151,000 37,424,000 
      acquired in-process research and development - related party
                 
      proceeds from issuance of common stock in initial public offering
                
      payment of initial public offering costs
              -313,000 -2,820,000 -16,470,000 -99,000 
      net increase in cash, cash equivalents and restricted cash
          8,176,000 50,127,000   -12,659,000 -22,552,000   
      operating lease
                
      conversion of convertible promissory notes and interest into common stock
                 
      conversion of warrant liability into equity
                
      settlement of espp liability in common stock
                  
      net amortization of premiums and discounts on marketable securities
           -1,273,000       
      proceeds from issuances of stock under espp
                 
      proceeds from exercise of stock options
           7,000 80,000 80,000     
      unpaid initial public offering costs
               -1,411,000 1,176,000 548,000 
      non-cash lease costs
                  
      proceeds from issuance of common stock
                  
      proceeds from issuance of convertible promissory notes
                  
      accrued interest exchanged for convertible promissory notes
                  
      issuance of takeda warrants in connection with takeda license
                  
      issuance of common stock in connection with takeda license
                  
      purchase of property and equipment
                  
      conversion of convertible promissory notes and accrued interest into common stock
                  
      accounts payable and accrued expenses
                 -1,868,000 
      net decrease in cash and cash equivalents
                 -13,314,000 
      cash and cash equivalents—beginning of period
                 124,566,000 
      cash and cash equivalents—end of period
                 111,252,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.